Damon Wang

Company: Nucyrna Therapeutics

Job title: Co-Founder & CEO

Seminars:

Workshop E: Evaluating Toxicity in Preclinical Models: Reviewing Distribution & Safety of Delivery Methodology to Produce More Effective & Tolerable Therapeutics 2:30 pm

This workshop provides an in-depth exploration of key considerations in intrathecal and conjugate delivery techniques, aiming to achieve optimal distribution and penetrance while addressing factors such as affinity, efficacy, and specificity for efficient oligonucleotide delivery to the brain. Participants will gain insights into: Quantifying and mitigating acute neurotoxicity induced by ASOs and siRNAs in the…Read more

day: Pre-Conference Workshop Day Track E